Man and woman looking at laptop.

VYVGART cost and coverage

Here to help you navigate your VYVGART treatment journey.

Insurance and coverage Cost and access Understanding your insurance

Download the VYVGART insurance and coverage guide

icon/psp/ncm
icon/psp/ncm

Insurance and coverage

VYVGART has coveragecoverage from both national and regional payers, with about 85% of insurance plans offering coverage for VYVGART for IV infusion treatment. However, your insurance coverage for VYVGART depends on the terms and conditions listed in your insurance plan.

90FF89CB-5032-4706-89AC-B93D8CAABAE5@3x

VYVGART insurance and coverage guide

As you navigate your VYVGART treatment journey, use this guide that may help you understand the insurance process and how the team at My VYVGART Path may assist you in accessing VYVGART.

DOWNLOAD NOW

Cost and access

Your out-of-pocket cost for VYVGART may vary depending on your insurance plan. Many different factors may impact your treatment cost.

Your insurer’s co-payco-pay, co-insuranceco-insurance, deductibledeductible, and out-of-pocket maximumout-of-pocket maximum requirements for medications may affect your out-of-pocket costs.

Where you receive treatment, your site of caresite of care, and whether your provider or specialty pharmacy is in networknetwork may also affect your out-of-pocket costs.

How we can help you navigate the insurance process

My VYVGART Path can help you and your doctor’s office navigate the insurance process and understand your plan’s coverage requirements for VYVGART. Once your doctor enrolls you in My VYVGART Path, the team will complete a benefits investigation to help provide you with personalized information about your insurance coverage, potential financial assistance programs, and possible out-of-pocket costs.

 

Co-pay program

Download the VYVGART brochure

If you have commercial or private insurance, you may be eligible for assistance through the VYVGART Co-pay Program.

Download now

My VYVGART Path Patient Support Program

My VYVGART Path Patient Support Program

If you do not have health insurance, you may be eligible for financial assistance through the My VYVGART Path Patient Support Program.

Download now

Doctor discussion guide

Doctor Discussion Guide

Start the conversation and ask your doctor to sign you up for My VYVGART Path. Once you’re enrolled, you’ll be able to have access to information, resources, and personalized support.

Download now

  

VYVGART insurance and coverage guide

Use this guide to help navigate the insurance process and understand potential next steps.

DOWNLOAD NOW

Understanding your insurance

Getting started on treatment and navigating insurance can feel complicated. Expand each term to learn more about the basics of health insurance.

Medicare is a federal insurance program for adults aged 65 years or older. Younger individuals with certain types of disabilities or permanent kidney failure may also qualify.

Medicare may cover treatments for FDA-approved indications. This insurance program has 4 parts (A, B, C, and D), each providing a specific type of coverage.

  • Medicare Part A covers inpatient hospital stays, care in a skilled nursing facility, hospice care, and some home healthcare
  • Medicare Part B helps cover doctors’ and other healthcare providers’ services, outpatient care, home healthcare, durable medical equipment, and many preventive services
  • Medicare Part C (Medicare Advantage) is a Medicare-approved plan from a private company that offers an alternative to Original Medicare for your health and drug coverage. These “bundled” plans include Part A, Part B, and usually Part D
  • Medicare Part D helps cover the cost of prescription drugs
  • Medicare Supplement Insurance (Medigap) is extra insurance you can buy from a private company that helps pay your share of costs in Original Medicare  

Medicaid is a health insurance program that is administered by the government. Medicaid may provide coverage for families with low income, individuals who are pregnant, older adults, and people with disabilities. Each state has different eligibility rules.

Commercial insurance, also called private insurance, is provided and administered by a private insurance company. You may receive this insurance from your employer or purchase it from the Health Insurance Marketplace.

A summary of benefits is a short, plain-language summary about a health plan’s benefits and coverage. You can use it to compare the benefits and cost of different insurance plans.

Most insurance companies need to pre-approve specific healthcare services, prescriptions, or equipment before you can receive it. This process for getting approval is called a prior authorization (pre-authorization).

Each insurance company's timeline for the VYVGART prior authorization process may vary. Medicare does not require prior authorization. Reach out to your Nurse Case Manager if you have questions about the process or need an update.

To get started, ask your neurologist to enroll you in

My VYVGART Path

After you and your neurologist decide on VYVGART, your doctor's office will be able to enroll you in My VYVGART Path.

Once you are enrolled, you will receive a call from a Nurse Case Manager and get a welcome kit in the mail.

Already enrolled in My VYVGART Path?

Call 1-833-MY-PATH-1 (1-833-697-2841) to talk with a Nurse Case Manager.

Use this

discussion guide

to talk to your neurologist about whether VYVGART is right for you.

VYVGART (efgartigimod alfa-fcab) Injection for Intravenous Use 400 mg/20 mL vial; VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) Subcutaneous Injection 180 mg/mL and 2000 U/mL vial
VYVGART (efgartigimod alfa-fcab) Injection for Intravenous Use 400 mg/20 mL vial; VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) Subcutaneous Injection 180 mg/mL and 2000 U/mL vial

Still have questions? Call 1-833-VYVGART (1-833-898-4278) to speak with an educator about gMG, how VYVGART works, study data, cost and coverage, and more.

What is the most important information I should know about VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. More patients on efgartigimod alfa-fcab vs placebo had below normal levels for white blood cell counts, lymphocyte counts, and neutrophil counts. The majority of infections and observed lower white blood cell counts were mild to moderate in severity. Your healthcare provider should check you for infections before starting treatment, during treatment, and after treatment with VYVGART or VYVGART HYTRULO. Tell your healthcare provider if you have any history of infections. Tell your healthcare provider right away if you have signs or symptoms of an infection during treatment with VYVGART or VYVGART HYTRULO such as fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain. If a serious infection occurs, your doctor will treat your infection and may even stop your VYVGART or VYVGART HYTRULO treatment until the infection has resolved.
  • Undesirable immune reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause the immune system to have undesirable reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. In clinical studies, the reactions were mild or moderate and occurred within 1 hour to 3 weeks of administration, and the reactions did not lead to treatment discontinuation. Your healthcare provider should monitor you during and after treatment and discontinue VYVGART or VYVGART HYTRULO if needed. Tell your healthcare provider immediately about any undesirable reactions to VYVGART or VYVGART HYTRULO.

Before taking VYVGART or VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • Have a history of infection or you think you have an infection.
  • Have received or are scheduled to receive a vaccine (immunization). Discuss with your healthcare provider whether you need to receive age-appropriate immunizations before initiation of a new treatment cycle with VYVGART or VYVGART HYTRULO. The use of vaccines during treatment with VYVGART or VYVGART HYTRULO has not been studied, and the safety with live or live-attenuated vaccines is unknown. Administration of live or live-attenuated vaccines is not recommended during treatment with VYVGART or VYVGART HYTRULO.
  • Are pregnant or plan to become pregnant and are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects of efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART for IV infusion and what is VYVGART HYTRULO for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.

What is the most important information I should know about VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. More patients on efgartigimod alfa-fcab vs placebo had below normal levels for white blood cell counts, lymphocyte counts, and neutrophil counts. The majority of infections and observed lower white blood cell counts were mild to moderate in severity. Your healthcare provider should check you for infections before starting treatment, during treatment, and after treatment with VYVGART or VYVGART HYTRULO. Tell your healthcare provider if you have any history of infections. Tell your healthcare provider right away if you have signs or symptoms of an infection during treatment with VYVGART or VYVGART HYTRULO such as fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain. If a serious infection occurs, your doctor will treat your infection and may even stop your VYVGART or VYVGART HYTRULO treatment until the infection has resolved.
  • Undesirable immune reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause the immune system to have undesirable reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. In clinical studies, the reactions were mild or moderate and occurred within 1 hour to 3 weeks of administration, and the reactions did not lead to treatment discontinuation. Your healthcare provider should monitor you during and after treatment and discontinue VYVGART or VYVGART HYTRULO if needed. Tell your healthcare provider immediately about any undesirable reactions to VYVGART or VYVGART HYTRULO.

Before taking VYVGART or VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • Have a history of infection or you think you have an infection.
  • Have received or are scheduled to receive a vaccine (immunization). Discuss with your healthcare provider whether you need to receive age-appropriate immunizations before initiation of a new treatment cycle with VYVGART or VYVGART HYTRULO. The use of vaccines during treatment with VYVGART or VYVGART HYTRULO has not been studied, and the safety with live or live-attenuated vaccines is unknown. Administration of live or live-attenuated vaccines is not recommended during treatment with VYVGART or VYVGART HYTRULO.
  • Are pregnant or plan to become pregnant and are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects of efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART for IV infusion and what is VYVGART HYTRULO for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.

Questions? Call 1-833-VYVGART
(1-833-898-4278)

This site is intended for patients and caregivers.

Disclaimer | Privacy Policy | Contact Us |

Prescribing Information
VYVGART for IV infusion Prescribing Information VYVGART Hytrulo for subcutaneous injection Prescribing Information

VYVGART is a registered trademark of argenx.
VYVGART Hytrulo is a trademark of argenx.

For U.S. audiences only.

©2023 argenx 

US-VYV-23-00233 V3 11/2023

argenx